Showing results (31-40 of 72) with videos related to
Sort By:
Pageof 8
Molecular Cancer|February 2, 2010
Effects of nilotinib on regulatory T cells: the dose mattersFei Fei, Yingzhe Yu, Anita Schmitt, et al.Cancer Immunology, Immunotherapy : CII|January 1, 2005
Dendritic cells generated from acute myeloid leukemia (AML) blasts maintain the expression of immunogenic leukemia associated antigensLi Li, Peter Reinhardt, Anita Schmitt, et al.Cancer Medicine|December 14, 2020
Characteristics and mechanisms to control a COVID-19 outbreak on a leukemia and stem cell transplantation unitJochen Greiner, Marlies Götz, Waltraud Malner-Wagner, et al.British Journal of Haematology|July 8, 2022
Enhanced stimulation of antigen-specific immune responses against nucleophosmin 1 mutated acute myeloid leukaemia by an anti-programmed death 1 antibodyJochen Greiner, Marlies Goetz, Patrick J Schuler, et al.Science (New York, N.Y.)|August 2, 2014
Early ⁵⁶Ni decay gamma rays from SN2014J suggest an unusual explosionRoland Diehl, Thomas Siegert, Wolfgang Hillebrandt, et al.Blood|May 18, 2012
Mutated regions of nucleophosmin 1 elicit both CD4(+) and CD8(+) T-cell responses in patients with acute myeloid leukemiaJochen Greiner, Yoko Ono, Susanne Hofmann, et al.Experimental Hematology|September 13, 2002
Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemiaJochen Greiner, Mark Ringhoffer, Masanori Taniguchi, et al.Experimental Hematology|December 13, 2006
Chronic myeloid leukemia cells express tumor-associated antigens eliciting specific CD8+ T-cell responses and are lacking costimulatory moleculesMichael Schmitt, Li Li, Krzysztof Giannopoulos, et al.Regenerative Medicine|May 1, 2007
Efficient transient genetic labeling of human CD34+ progenitor cells for in vivo applicationJuliane M I Wiehe, Carola Niesler, Jan Torzewski, et al.Cancer Immunity|July 17, 2003
Reconstitution of CD40 and CD80 in dendritic cells generated from blasts of patients with acute myeloid leukemiaLi Li, Anita Schmitt, Peter Reinhardt, et al.Pageof 8